PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

School toolkits

Supporting children and young people with JIA

2023-06-01
(Press-News.org) Children and young people naturally spend a large amount of their time at school, college or in other educational settings. Whilst most children with JIA are able to access education, many require adaptations or specific support to enable them to fully engage in learning. But families of children with JIA report lack of awareness and understanding, and believe that schools need special resources to be able to support these children and young people.

In the UK, Juvenile Arthritis Research (JAR) has developed a toolkit to allow teachers and school staff to confidently support children with JIA, and the initial rollout was assessed via a network of parents. In the first 6 months the toolkits had been delivered to 100 schools – potentially reaching over 100,000 families.

In the abstract presented at the 2023 EULAR congress, Rebecca Beesley from the JAR charity explains that the toolkit includes a variety of resources to help increase awareness around JIA, both in schools and for parents. This in turn could help improve diagnosis times, as well as help achieve timely access to treatment.

To do this, the toolkit contains information about what JIA is, resources for schools to provide targeted interventions, and information on how schools can successfully support children with JIA. Finally, each toolkit also contains materials to help staff explain arthritis to children in a classroom or group assembly setting, as well as digital copies of key materials for distribution to parents and families.

A short web-based survey was used to assess impressions of the initial rollout, with very positive feedback so far. The results show that some schools have used the toolkit resources to train staff and give lessons to children to explain what arthritis is; others have displayed posters highlighting the key signs and symptoms of JIA.

“Wow – it's fantastic,” said one teacher who had used the toolkit. “The student presentation is particularly impressive with how it translates all the key information in a child-friendly manner.”

The JAR team are confident that the development and supply of a toolkit specifically for use in education has already helped raise awareness that some children do get arthritis, while also providing resources to train school staff to be able to offer support. Building in the experience and skills of parents and teachers in the development phase has ensured all resources are relevant, addressing the needs of both families and schools. 

Toolkits can be requested free of charge by schools and educational settings in the UK from www.jarproject.org/toolkit

Source:

Beesley R, Beesley R. Supporting children and young people with Juvenile Idiopathic Arthritis in schools, colleges and other educational settings through School Toolkits. Presented at EULAR 2023; Abstract OP0160.

About EULAR

EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.

Contact

EULAR Communications, communications@eular.org

Notes to Editors
EULAR Recommendations
EULAR School of Rheumatology
EULAR Press Releases

END


ELSE PRESS RELEASES FROM THIS DATE:

Long-term risks of targeted therapies

2023-06-01
Janus kinase inhibitors (JAKi) and biologics are the cornerstone of modern treatment for rheumatoid arthritis (RA). But there have been concerns over long-term side effects. New data from a national healthcare database offer reassuring findings for overall cancers and cardiovascular disease (CVD). Patients with inflammatory rheumatic diseases have an increased risk of CVD compared to the general population.1 In acknowledgement of this, EULAR – the European Alliance of Associations for Rheumatology – has published recommendations for cardiovascular risk management ...

Managing anxiety and depression in arthritis

2023-06-01
Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and poor health outcomes.2 The EULAR recommendations emphasize the need to assess mental health regularly;1 however, little is known about the association between self-management and mental health in people with inflammatory arthritis. At the 2023 EULAR congress, Vestergaard and colleagues report on their cross-sectional study in Denmark. This included 42,407 adult patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or spondylarthritis (axSpA). The aim was to find ...

Healthy lifestyle and mortality in osteoarthritis

2023-06-01
In this work, data from the UK Biobank were used to investigate the association of both individual and combined healthy lifestyle factors with the risk of all-cause and cause-specific mortality among 104,142 people with osteoarthritis. The researchers gave each person a score for their lifestyle, based on their body mass index (BMI) and self-reported diet, sleep duration, physical activity, sedentary time, social connection, smoking, and alcohol drinking – all factors thought to be associated with health. Overall, there were 9,915 deaths recorded after the first 2 years’ ...

The European Alliance of Associations For Rheumatology, EULAR, announces its strategy for 2024 – 2028

2023-06-01
Over the period 2018 – 2023, EULAR, the leading organisation in RMDs, has grown substantially and has been professionalised in every aspect. For example, EULAR has increased its impact on RMDs through the development of new services provided by the EULAR Research Centre (ERC). Despite the disruption of routine procedures brought about by the pandemic, EULAR overcame the substantial associated challenges, providing continued access to education and networking for the RMD community. “We have made tremendous progress by setting up two virtual congresses and one fully hybrid congress, and we have ...

EULAR launches ‘RheumaFacts’, a unique and Pan-European data repository of rheumatic and musculoskeletal disease indicators

2023-06-01
The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of RheumaFacts, an innovative and unique resource of facts and figures related to rheumatic and musculoskeletal diseases (RMDs) across Europe. Strategically developed to support EULAR’s mission of reducing the impact of RMDs on individuals and society, RheumaFacts will serve as a powerful tool to provide healthcare professionals, researchers, policymakers, and patients with data-driven insights on the status of rheumatologic care across EULAR’s ...

EULAR launches first European patient-filled survey about the impact of rheumatic and musculoskeletal diseases on individual’s lives

2023-06-01
The European Alliance of Associations for Rheumatology (EULAR) has announced the launch of the EULAR Impact of RMDs Survey, an online questionnaire targeted directly at RMD patients. The data collected through this survey will be an important resource for researchers, healthcare professionals, and patients alike, providing a comprehensive database of patient-reported outcomes on their healthcare situation, and how the illness affects their social and occupational lives. By collecting and analysing data from a large number of patients with RMDs on a recurring basis, the survey will provide valuable insights into the burden of disease and help improve the overall care for people living with ...

Rheumatic and musculoskeletal diseases (RMDs) often accelerate lethal comorbidities

2023-06-01
Rheumatic and musculoskeletal diseases (RMDs) include over 200 diseases that affect over 120 million Europeans of all ages. Aside from the significant direct impact RMDs have on patients, many of them also pose a further significant risk to the population by virtue of accelerating many comorbidities if the RMD is not treated appropriately. The most significant comorbidities of inflammatory RMDs include cardiovascular disease, lung disease, cancers, gastrointestinal disease, and mental health disorders.[1] Many of these comorbidities are prioritised by the EU as key non-communicable ...

Stand Up to Cancer announces $1.5 million commitment from Pancreatic Cancer North America to fund pancreatic cancer vaccine research

Stand Up to Cancer announces $1.5 million commitment from Pancreatic Cancer North America to fund pancreatic cancer vaccine research
2023-06-01
LOS ANGELES – June 1, 2023 – Stand Up To Cancer® (SU2C) and Pancreatic Cancer North America (PCNA) today announced that PCNA will contribute $1.5 million to SU2C in support of critically needed research focused on pancreatic cancer, which has the highest mortality rate of all major cancers.      One of the projects supported by PCNA will include a correlative study that analyzes data from a previous Phase 1 clinical trial conducted by a Research Team funded through the SU2C Convergence program and led by researchers at Memorial ...

Rethink, rewrite, redefine—how biodegradable plastics are reshaping sustainability

Rethink, rewrite, redefine—how biodegradable plastics are reshaping sustainability
2023-06-01
The University of California San Diego’s vision is to be a student-centered, research-focused, service-oriented public university. There are countless examples across campus of the ways these three pillars are upheld, but it is unique to find all three incorporated at once. Now a new book on algae-based biodegradable plastics showcases student research and the monumental potential it has to change consumerism on a global scale. Statistics on the environmental damage of plastics are stark: in 2018, U.S. landfills received 27 million tons of plastic (U.S. Environmental Protection Agency); ...

ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

2023-06-01
Five leading cancer research organizations in the United States are jointly announcing the start of patient enrollment in Molecular Analysis for Combination Therapy Choice (ComboMATCH), a unique, precision medicine initiative to test new combinations of cancer drugs guided by tumor biology. The Alliance for Clinical Trials in Oncology, Children's Oncology Group, ECOG-ACRIN Cancer Research Group, NRG Oncology, and SWOG Cancer Research Network plan to conduct many early-phase treatment trials through this platform in collaboration with the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). NCI is part of ...

LAST 30 PRESS RELEASES:

Findings of large-scale study on 572 Asian families supports gene-directed management of BRCA1 and BRCA2 gene carriers in Singapore

Many children with symptoms of brain injuries and concussions are missing out on vital checks, national US study finds

Genetic hope in fight against devastating wheat disease

Mutualism, from biology to organic chemistry?

POSTECH Professor Yong-Young Noh resolves two decades of oxide semiconductor challenges, which Is published in prestigious journal Nature

Could fishponds help with Hawaiʻi’s food sustainability?

International network in Asia and Europe to uncover the mysteries of marine life

Anthropologist documents how women and shepherds historically reduced wildfire risk in Central Italy

Living at higher altitudes in India linked to increased risk of childhood stunting

Scientists discover a new signaling pathway and design a novel drug for liver fibrosis

High-precision blood glucose level prediction achieved by few-molecule reservoir computing

The importance of communicating to the public during a pandemic, and the personal risk it can lead to

Improving health communication to save lives during epidemics

Antimicrobial-resistant hospital infections remain at least 12% above pre-pandemic levels, major US study finds

German study finds antibiotic use in patients hospitalised with COVID-19 appears to have no beneficial effect on clinical outcomes

Targeting specific protein regions offers a new treatment approach in medulloblastoma

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Cardiovascular societies propel plans forward for a new American Board of Cardiovascular Medicine

Hebrew SeniorLife selected for nationwide collaborative to accelerate system-wide spread of age-friendly care for older adults

New tool helps identify babies at high-risk for RSV

Reno/Sparks selected to be part of Urban Heat Mapping Campaign

Advance in the treatment of acute heart failure identified

AGS honors Dr. Rainier P. Soriano with Dennis W. Jahnigen Memorial Award at #AGS24 for proven excellence in geriatrics education

New offshore wind turbines can take away energy from existing ones

Unprecedented research probes the relationship between sleep and memory in napping babies and young children

Job losses help explain increase in drug deaths among Black Americans

Nationwide, 32 local schools win NFL PLAY 60 grants for physical activity

Exposure to noise – even while in the egg – impairs bird development and fitness

Vitamin D availability enhances antitumor microbes in mice

Conservation actions have improved the state of biodiversity worldwide

[Press-News.org] School toolkits
Supporting children and young people with JIA